跳至主要内容
临床试验/ACTRN12624000024549
ACTRN12624000024549尚未招募Unknown

A randomised cross-over trial evaluating glycaemic, clinical and psychometric effects associated with the use continuous glucose monitoring (CGM) in adults with Cystic Fibrosis Related Diabetes (CFRD).

Metro North Hospital and Health Services0 个研究点目标入组 36 人开始时间: 2024年1月11日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 o limit(—)
性别
All

入选标准

  • Age of >21 years
  • On insulin therapy
  • Confirmed CFRD based on current ADA criteria
  • Most recent HbA1c above the target of 7.0%
  • Participant being able to complete the study protocol

排除标准

  • Unable to use Smartphone application
  • Unable to self-insert CGM
  • Incompatible Smartphone
  • Lacking capacity to engage in all aspects of study protocol

研究者

发起方
Metro North Hospital and Health Services

相似试验